Ocular Therapeutix (OCUL) Notes Payables (2013 - 2023)

Ocular Therapeutix's Notes Payables history runs 9 years deep, the most recent figure standing at $2.1 million for Q2 2023.

• In Q2 2023, Notes Payables changed N/A year-over-year to $2.1 million; the TTM figure through Jun 2023 stood at $2.1 million (changed N/A YoY), while the FY2020 annual figure was $8.3 million, changed N/A from the prior year.
• Notes Payables was $2.1 million for Q2 2023 at Ocular Therapeutix, down from $8.3 million in the prior quarter.
• In the past five years, Notes Payables ranged from a high of $8.3 million in Q4 2020 to a low of $2.1 million in Q1 2020.
• Historically, Notes Payables has averaged $5.2 million across 3 years, with a median of $5.2 million in 2020.
• Biggest YoY gain for Notes Payables was 299.71% in 2021; the steepest drop was 299.71% in 2021.
• A 3-year view of Notes Payables shows it stood at $8.3 million in 2020, then changed by 0.0% to $8.3 million in 2021, then slumped by 74.87% to $2.1 million in 2023.
• The last three Notes Payables figures came in at $2.1 million (Q2 2023), $8.3 million (Q1 2021), and $8.3 million (Q4 2020), per Business Quant data.